Evotec Dirección
Dirección controles de criterios 3/4
El CEO de Evotec's es Mario Polywka, nombrado en Jan 2024, tiene una permanencia de menos de un año. posee directamente un 0.007% de las acciones de la empresa, con un valor de €109.29K. La antigüedad media del equipo directivo y de la junta directiva es de 1.6 años y 4.8 años, respectivamente.
Información clave
Mario Polywka
Chief Executive Officer (CEO)
€60.0k
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | less than a year |
| Participación del CEO | 0.007% |
| Permanencia media de la dirección | 2.3yrs |
| Promedio de permanencia en la Junta Directiva | 4.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Investors Aren't Entirely Convinced By Evotec SE's (ETR:EVT) Revenues
Apr 10
These 4 Measures Indicate That Evotec (ETR:EVT) Is Using Debt Reasonably Well
Mar 05A Piece Of The Puzzle Missing From Evotec SE's (ETR:EVT) Share Price
Jan 09We Think Evotec (ETR:EVT) Can Stay On Top Of Its Debt
Oct 05Evotec (ETR:EVT) Has A Somewhat Strained Balance Sheet
Jun 28Is There An Opportunity With Evotec SE's (ETR:EVT) 37% Undervaluation?
May 14Does Evotec (ETR:EVT) Have A Healthy Balance Sheet?
Feb 25Evotec (ETR:EVT) Seems To Use Debt Quite Sensibly
Jul 29Is Now The Time To Look At Buying Evotec SE (ETR:EVT)?
May 16Is Evotec (ETR:EVT) A Risky Investment?
Apr 28Do Evotec's (ETR:EVT) Earnings Warrant Your Attention?
Mar 15At €36.91, Is It Time To Put Evotec SE (ETR:EVT) On Your Watch List?
Jan 10Evotec (ETR:EVT) Takes On Some Risk With Its Use Of Debt
Nov 14Is It Time To Consider Buying Evotec SE (ETR:EVT)?
Oct 10Evotec (ETR:EVT) Has A Somewhat Strained Balance Sheet
Aug 16Is It Time To Consider Buying Evotec SE (ETR:EVT)?
Jul 03Evotec SE's (ETR:EVT) CEO Looks Due For A Compensation Raise
Jun 07These 4 Measures Indicate That Evotec (ETR:EVT) Is Using Debt Reasonably Well
Apr 30Evotec SE's (ETR:EVT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 21Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -€84m |
| Sep 30 2023 | n/a | n/a | -€95m |
| Jun 30 2023 | n/a | n/a | -€103m |
| Mar 31 2023 | n/a | n/a | -€117m |
| Dec 31 2022 | €60k | n/a | -€176m |
| Sep 30 2022 | n/a | n/a | -€180m |
| Jun 30 2022 | n/a | n/a | €2m |
| Mar 31 2022 | n/a | n/a | €90m |
| Dec 31 2021 | €56k | n/a | €216m |
| Sep 30 2021 | n/a | n/a | €247m |
| Jun 30 2021 | n/a | n/a | €112m |
| Mar 31 2021 | n/a | n/a | €42m |
| Dec 31 2020 | €50k | n/a | €6m |
| Sep 30 2020 | n/a | n/a | €14m |
| Jun 30 2020 | n/a | n/a | €35m |
| Mar 31 2020 | n/a | n/a | €42m |
| Dec 31 2019 | €27k | n/a | €38m |
| Sep 30 2019 | n/a | n/a | €61m |
| Jun 30 2019 | n/a | n/a | €77m |
| Mar 31 2019 | n/a | n/a | €94m |
| Dec 31 2018 | €846k | €316k | €84m |
| Sep 30 2018 | n/a | n/a | €63m |
| Jun 30 2018 | n/a | n/a | €31m |
| Mar 31 2018 | n/a | n/a | €20m |
| Dec 31 2017 | €816k | €320k | €23m |
Compensación vs. Mercado: La compensación total de Mario($USD64.36K) está por debajo de la media de empresas de tamaño similar en el mercado German ($USD1.63M).
Compensación vs. Ingresos: La compensación de Mario ha aumentado mientras la empresa no es rentable.
CEO
Mario Polywka (60 yo)
less than a year
Permanencia
€60,000
Compensación
Dr. Mario Polywka, Ph D., D.Phil., serves as Director at Blacksmith Medicines, Inc. He was Independent Member of the Supervisory Board at Evotec SE since June 19, 2019 and also serves as its Chairman of th...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Chairman of the Management Board & Member of the Supervisory Board | less than a year | €60.00k | 0.0067% € 116.5k | |
| Chief Scientific Officer & Member of Management Board | 13.7yrs | €1.40m | 0.11% € 1.9m | |
| COO & Member of Management Board | 5.3yrs | €2.11m | 0.011% € 196.7k | |
| Chief Business Officer & Member of Management Board | 2.3yrs | €1.54m | sin datos | |
| CFO & Member of Management Board | 1.1yrs | sin datos | 0.029% € 504.2k | |
| Principal Accounting Officer and Senior Vice President of Group Accounting | no data | sin datos | sin datos | |
| Executive VP and Head of Global Investor Relations & ESG | no data | sin datos | sin datos | |
| EVP Global Head of Legal & Compliance | no data | sin datos | sin datos | |
| Senior VP & Head of Global Corporate Communications & Marketing | no data | sin datos | sin datos | |
| Senior Vice President of Programme Management & Clinical Operations | no data | €116.00k | sin datos | |
| Executive Vice President | no data | sin datos | sin datos | |
| EVP Head of Metabolic Diseases | no data | sin datos | sin datos |
2.3yrs
Permanencia media
56yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de EVT se considera experimentado (2.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Chairman of the Management Board & Member of the Supervisory Board | 4.9yrs | €60.00k | 0.0067% € 116.5k | |
| Independent Vice Chairperson of the Supervisory Board | 4.9yrs | €95.00k | sin datos | |
| Independent Chairperson of the Supervisory Board | 9.9yrs | €150.00k | sin datos | |
| Independent Member of Supervisory Board | 8.9yrs | €65.30k | sin datos | |
| Member of the Supervisory Board | 1.9yrs | €31.60k | sin datos | |
| Independent Member of Supervisory Board | 2.9yrs | €73.20k | sin datos |
4.9yrs
Permanencia media
60yo
Promedio de edad
Junta con experiencia: La junta directiva de EVT se considera experimentada (4.8 años de antigüedad promedio).